HCW Biologics Inc. (HCWB): Depreciation & Amortization
$1.04M
Year ended 2025-12-31
$600.0K
Trailing 12 months to 2026-06-30
+13.2%
3-year compound annual growth
+12.7%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.04M | -12.0% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $1.18M | +4.3% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $1.14M | +58.1% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $717.9K | +32.1% | 2024-05-15, From 2022-01-01 |
| 2021-12-31 | $543.6K | -5.1% | 2023-03-28, From 2021-01-01 |
| 2020-12-31 | $572.9K | n/a | 2022-03-29, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.04M | -12.0% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $344.0K | +103.6% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $704.0K | +6.7% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $11.54M | -41.2% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $246.0K | +138.8% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $173.0K | -12.2% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $1.15M | +2.3% |
| Talphera, Inc. (TLPH) | 2024-12-31 | $0 | -100.0% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $73.0K | -62.4% |
Compare HCWB, AVTX, CNTB, LYEL side by side · Screen every company in Pharmaceutical Preparations ↗